Tag: drug safety
-
Byetta / Januvia / Victoza: Update On Possible Association Between These Newer Diabetes Drugs And Pancreatic Cancer As A Side Effect
Drug Safety Regulatory Developments And The Ongoing Academic Discussions About Provocative 2013 Medical Journal Article By Peter Butler At UCLA (Posted by Tom Lamb at DrugInjuryWatch.com)We last wrote about the possible association between pancreatic…
-
Drug Safety Significance Of Adverse Reactions Reports For Xarelto Blood Thinner Pill Is Uncertain, At Best
Does The Apparently High Number Of Side Effects Cases From Germany Thus Far In 2013 Mean There Is Safety Signal, Or Is This All About Nothing (Posted by Tom Lamb at DrugInjuryWatch.com)On September 8,…
-
Cancer of The Pancreas: Possible Side Effect For Diabetics Who Use Byetta, Januvia, Or Victoza?
Diabetes Doctors And Drug Safety Watchdog Group Express More Concern Than Ever Following June 2013 BMJ Medical Journal Article (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-March 2013 we wrote this article, “Emerging Drug…
-
Emerging Drug Safety Issue: Possible Increased Risk Of Pancreatic Cancer With Byetta, Januvia, And Victoza — Little Is Known About Long-Term Effects
As “Pancreatitis Is On The Pathway Toward Pancreatic Cancer”, Medical Studies Needed To Determine If GLP-1 Diabetes Medications Linked To Cancers Or Malignancies Involving Pancreas (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: “Cancer of The Pancreas:…
-
Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe
Is The FDA Doing Enough About Birth Control Products That Contain Third Generation Or Fourth Generation Progestins And Are Associated With Higher Risks Of Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) A January 3,…
-
Despite FDA Regulations, Generic Drug Labels Often Failed To Match Brand Name Drug Safety Warnings
Two-Thirds Of The Generics Did Not Have Identical Labeling, And Up To 9% Showed Differences Of More Than 10 Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) A disturbing new study about drug labeling for generic medications…
-
December 2012 Pradaxa Update: Prescription / Sales Numbers And Drug Company Safety Study Results
It Has Been Far From Smooth Sailing For Pradaxa During The Two Years It Has Been Available In The United States (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported in this earlier article,…
-
Generic Drugs Post-Mensing Ruling: One Proposed Solution To The Legal Compensation And FDA Drug Safety Problems Supreme Court Created
At Least, This November 2012 Article In The New England Journal Of Medicine Makes The Point That Something Needs To Be Done Soon, Rather Than Later (Posted by Tom Lamb at DrugInjuryWatch.com) The June 2011…
-
The Drug-Induced Pancreatitis Safety Problem That Hangs Around Victoza Gets Another Look
The Relatively New Diabetes Medication Victoza From Novo Nordisk Was Only Approved By FDA In 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2012 The Annals of Pharmacotherapy published online before print this new…
-
Multaq Associated Lung Disease And Pulmonary Toxicity Pointed Out By New Safety Warnings In September 2012 Revised Label
Heart Drug Multaq Can Cause Pulmonary Fibrosis And Pneumonitis; Symptoms Are Inflammation Of The Lungs, Including Scarring And Thickening (Posted by Tom Lamb at DrugInjuryWatch.com) Multaq (dronedarone) is a drug used to treat abnormal heart rhythm (atrial…